Compounds > fingolimod hydrochloride
Page last updated: 2024-09-02

fingolimod hydrochloride and Hematologic Neoplasms

fingolimod hydrochloride has been researched along with Hematologic Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
East, JE; Subrahmanyam, PB; Tiper, IV; Webb, TJ1
Milstien, S; Nagahashi, M; Spiegel, S; Stevenson, CE; Takabe, K1

Reviews

2 review(s) available for fingolimod hydrochloride and Hematologic Neoplasms

ArticleYear
Sphingosine 1-phosphate signaling impacts lymphocyte migration, inflammation and infection.
    Pathogens and disease, 2016, Volume: 74, Issue:6

    Topics: Animals; Chemotaxis, Leukocyte; Cytokines; Disease Models, Animal; Fingolimod Hydrochloride; Hematologic Neoplasms; Host-Pathogen Interactions; Humans; Immune System; Immunosuppressive Agents; Infections; Inflammation; Lymphocytes; Lysophospholipids; Signal Transduction; Sphingosine; Transcription Factors

2016
Targeting sphingosine-1-phosphate in hematologic malignancies.
    Anti-cancer agents in medicinal chemistry, 2011, Volume: 11, Issue:9

    Topics: Animals; Fingolimod Hydrochloride; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Lysophospholipids; Phosphotransferases (Alcohol Group Acceptor); Propylene Glycols; Receptors, Lysosphingolipid; Sphingosine

2011